CPhI Worldwide, part of UBM Live’s Pharmaceutical Portfolio, has released the findings of its Pharma Insights report on R&D. According to the report, the R&D market is diversifying innovation with increased out/in licensing of technology, partnerships, and mergers. Improvements in evaluation have also been credited with helping the sector grow by 8%, with long-term objectives now being considered at earlier stages within the development process.   According to the report, the industry is...